| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| IDH1 | 10 | 0 | 0 | 10 |
| chromobox protein homolog 1 | 23 | 0 | 0 | 23 |
| geminin | 25 | 0 | 0 | 25 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
| phosphopantetheinyl transferase | 13 | 0 | 0 | 13 |
| bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
| euchromatic histone-lysine N-methyltransferase 2 | 33 | 0 | 0 | 33 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Tubulin--tyrosine ligase | 0 | 2 | 0 | 2 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 1 | 1 | 0 | 2 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 2 |
| Chain A, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain B, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain A, ADP-dependent glucokinase | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, phosphodiesterase-nucleotide pyrophosphatase | 0 | 1 | 0 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain B, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| RAR-related orphan receptor gamma | 24 | 0 | 0 | 24 |
| AR protein | 42 | 0 | 0 | 42 |
| regulator of G-protein signaling 4 | 16 | 0 | 0 | 16 |
| glucocorticoid receptor [Homo sapiens] | 32 | 0 | 0 | 32 |
| estrogen-related nuclear receptor alpha | 30 | 0 | 0 | 30 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 18 | 0 | 0 | 18 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 1 | 2 |
| Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 0 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| 2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 6 | 0 | 6 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 0 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 2 |
| GTP:AMP phosphotransferase AK3, mitochondrial | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 0 | 1 | 1 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 2 |
| P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 2 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
| Glycine--tRNA ligase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 2 |
| Adenosine deaminase-like protein | 0 | 0 | 0 | 1 |
| Protease | 0 | 1 | 1 | 2 |
| P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 2 | 2 |
| ATP-dependent phosphofructokinase | 12 | 0 | 0 | 12 |
| glp-1 receptor, partial | 12 | 0 | 0 | 12 |
| thioredoxin reductase | 21 | 0 | 0 | 21 |
| GLS protein | 19 | 0 | 0 | 19 |
| estrogen nuclear receptor alpha | 43 | 0 | 0 | 43 |
| NPYLR7B | 0 | 0 | 2 | 2 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
| flap endonuclease 1 | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 | 14 | 0 | 0 | 14 |
| ATP-binding cassette sub-family C member 3 | 0 | 16 | 0 | 16 |
| Multidrug resistance-associated protein 4 | 0 | 16 | 0 | 17 |
| Bile salt export pump | 0 | 32 | 0 | 32 |
| Beta-2 adrenergic receptor | 0 | 6 | 5 | 12 |
| Beta-1 adrenergic receptor | 0 | 6 | 4 | 10 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 5 | 3 | 8 |
| Delta-type opioid receptor | 0 | 1 | 1 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 2 | 5 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 5 | 6 |
| Canalicular multispecific organic anion transporter 1 | 0 | 16 | 0 | 16 |
| TDP1 protein | 35 | 0 | 0 | 35 |
| peroxisome proliferator activated receptor gamma | 20 | 0 | 0 | 20 |
| Cellular tumor antigen p53 | 21 | 0 | 0 | 21 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Prostacyclin receptor | 0 | 2 | 1 | 3 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Luciferase | 12 | 0 | 0 | 12 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| 15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
| GLI family zinc finger 3 | 36 | 0 | 0 | 36 |
| thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
| estrogen receptor 2 (ER beta) | 13 | 0 | 0 | 13 |
| nuclear receptor subfamily 1, group I, member 3 | 18 | 0 | 0 | 18 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 19 | 0 | 0 | 19 |
| retinoic acid nuclear receptor alpha variant 1 | 26 | 0 | 0 | 26 |
| retinoid X nuclear receptor alpha | 19 | 0 | 0 | 19 |
| pregnane X nuclear receptor | 25 | 0 | 0 | 25 |
| G | 10 | 0 | 0 | 10 |
| peroxisome proliferator-activated receptor delta | 14 | 0 | 0 | 14 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 21 | 0 | 0 | 21 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 19 | 0 | 0 | 19 |
| activating transcription factor 6 | 10 | 0 | 0 | 10 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 10 | 0 | 0 | 10 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform 2 | 25 | 0 | 0 | 25 |
| histone deacetylase 9 isoform 3 | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 23 | 0 | 0 | 23 |
| lamin isoform A-delta10 | 27 | 0 | 0 | 27 |
| Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
| Interferon beta | 16 | 0 | 0 | 16 |
| HLA class I histocompatibility antigen, B alpha chain | 10 | 0 | 0 | 10 |
| Glutamate receptor 2 | 12 | 0 | 0 | 12 |
| Nicotinate phosphoribosyltransferase | 0 | 3 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 10 | 0 | 0 | 10 |
| cytochrome P450 2C9, partial | 10 | 0 | 0 | 10 |
| ORF73 | 0 | 0 | 1 | 1 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 8 | 0 | 0 | 8 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 8 | 0 | 0 | 8 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 3 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 14 | 1 | 15 |
| Spike glycoprotein | 14 | 0 | 1 | 15 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 16 | 0 | 0 | 16 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 15 | 0 | 0 | 15 |
| cytochrome P450 2D6 | 20 | 0 | 0 | 20 |
| glucocerebrosidase | 6 | 0 | 0 | 6 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
| DNA polymerase iota isoform a (long) | 12 | 0 | 0 | 12 |
| DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 15 | 0 | 0 | 15 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 6 |
| Carbonic anhydrase 2 | 0 | 4 | 0 | 7 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 1 | 1 | 0 | 2 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 1 | 1 | 0 | 2 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 0 | 2 | 0 | 4 |
| Adenosine receptor A2a | 0 | 2 | 0 | 4 |
| Substance-P receptor | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 5 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 14 | 1 | 1 | 16 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 8 | 1 | 9 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
| Chain A, Beta-lactamase | 8 | 0 | 0 | 8 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| SMAD family member 2 | 11 | 0 | 0 | 11 |
| Fumarate hydratase | 8 | 0 | 0 | 8 |
| USP1 protein, partial | 9 | 0 | 0 | 9 |
| SMAD family member 3 | 11 | 0 | 0 | 11 |
| Microtubule-associated protein tau | 13 | 0 | 0 | 13 |
| Smad3 | 4 | 0 | 0 | 4 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| progesterone receptor | 16 | 0 | 0 | 16 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| farnesoid X nuclear receptor | 9 | 0 | 0 | 9 |
| polyprotein | 8 | 0 | 0 | 8 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| caspase-3 | 4 | 0 | 0 | 4 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
| aryl hydrocarbon receptor | 12 | 0 | 0 | 12 |
| thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
| Histone H2A.x | 9 | 0 | 0 | 9 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| cytochrome P450 2D6 isoform 1 | 15 | 0 | 0 | 15 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
| cytochrome P450 2C19 precursor | 9 | 0 | 0 | 9 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 11 | 0 | 0 | 11 |
| caspase-3 | 3 | 0 | 0 | 3 |
| heat shock protein beta-1 | 7 | 0 | 0 | 7 |
| huntingtin isoform 2 | 4 | 0 | 0 | 4 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
| plasminogen precursor | 5 | 0 | 0 | 5 |
| urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
| nuclear receptor ROR-gamma isoform 1 | 10 | 0 | 0 | 10 |
| survival motor neuron protein isoform d | 10 | 0 | 0 | 10 |
| cytochrome P450 3A4 isoform 1 | 14 | 0 | 0 | 14 |
| Gamma-aminobutyric acid receptor subunit pi | 14 | 0 | 1 | 15 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 8 | 0 | 0 | 8 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 18 | 0 | 18 |
| Polycomb protein EED | 0 | 2 | 0 | 2 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 8 | 0 | 8 |
| Muscarinic acetylcholine receptor M2 | 0 | 14 | 3 | 21 |
| Muscarinic acetylcholine receptor M4 | 0 | 17 | 3 | 23 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 5 | 0 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 17 | 3 | 23 |
| Alpha-2A adrenergic receptor | 0 | 16 | 2 | 18 |
| Neuronal acetylcholine receptor subunit alpha-4 | 3 | 3 | 2 | 9 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
| Muscarinic acetylcholine receptor M1 | 0 | 15 | 3 | 22 |
| Neuronal acetylcholine receptor subunit beta-2 | 3 | 3 | 2 | 9 |
| D(2) dopamine receptor | 0 | 11 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 14 | 0 | 1 | 15 |
| Alpha-1B adrenergic receptor | 0 | 7 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit delta | 14 | 0 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 14 | 0 | 1 | 15 |
| Alpha-2C adrenergic receptor | 0 | 13 | 2 | 15 |
| 5-hydroxytryptamine receptor 1A | 0 | 13 | 3 | 16 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 14 | 0 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 14 | 0 | 1 | 15 |
| Muscarinic acetylcholine receptor M3 | 0 | 15 | 3 | 21 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| D(1A) dopamine receptor | 0 | 11 | 0 | 11 |
| D(4) dopamine receptor | 0 | 3 | 0 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 14 | 0 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 14 | 0 | 1 | 15 |
| Sodium-dependent noradrenaline transporter | 0 | 12 | 0 | 12 |
| Histamine H2 receptor | 0 | 9 | 2 | 11 |
| Alpha-1D adrenergic receptor | 0 | 15 | 4 | 19 |
| Substance-P receptor | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2A | 0 | 18 | 0 | 18 |
| 5-hydroxytryptamine receptor 2C | 0 | 20 | 0 | 20 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 14 | 0 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 14 | 0 | 1 | 15 |
| 5-hydroxytryptamine receptor 1B | 0 | 13 | 2 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 14 | 0 | 1 | 15 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 9 | 0 | 9 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 21 | 5 | 27 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 11 | 0 | 11 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 17 | 0 | 17 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 10 | 1 | 11 |
| Histamine H2 receptor | 11 | 1 | 2 | 17 |
| 5-hydroxytryptamine receptor 6 | 0 | 13 | 0 | 13 |
| Cytochrome P450 2J2 | 0 | 4 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 14 | 0 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 14 | 0 | 1 | 15 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
| Inositol monophosphatase 1 | 7 | 0 | 0 | 7 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 9 | 0 | 9 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 15 | 1 | 16 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
| GABA theta subunit | 14 | 0 | 1 | 15 |
| Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 9 | 0 | 0 | 9 |
| Ataxin-2 | 19 | 0 | 0 | 19 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 14 | 0 | 1 | 15 |
| Histamine H4 receptor | 0 | 4 | 2 | 6 |
| Heparanase | 0 | 0 | 2 | 2 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 6 | 3 | 13 |
| Muscarinic acetylcholine receptor M3 | 0 | 6 | 3 | 12 |
| Muscarinic acetylcholine receptor M4 | 0 | 7 | 2 | 12 |
| Muscarinic acetylcholine receptor M5 | 0 | 7 | 2 | 12 |
| Muscarinic acetylcholine receptor M2 | 0 | 6 | 2 | 12 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 2 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor | 0 | 3 | 1 | 4 |
| Cytochrome P450 2D6 | 0 | 8 | 0 | 8 |
| Alpha-1A adrenergic receptor | 0 | 4 | 6 | 10 |
| Alpha-1B adrenergic receptor | 0 | 4 | 5 | 9 |
| Histamine H3 receptor | 0 | 2 | 2 | 4 |
| histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 0 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 2 | 1 | 5 |
| B1 bradykinin receptor | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 7 | 0 | 0 | 7 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| mitogen-activated protein kinase 1 | 8 | 0 | 0 | 8 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 3 |
| Lysine-specific histone demethylase 1A | 0 | 2 | 0 | 2 |
| NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 3 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 4 | 0 | 4 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 3 | 2 | 5 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 1 | 2 |
| Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 4 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 0 | 1 | 1 |
| GALC protein | 6 | 0 | 0 | 6 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 3 | 2 | 6 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 3 | 2 | 6 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 3 | 2 | 6 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 3 | 2 | 6 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 3 | 2 | 6 |
| Delta-type opioid receptor | 0 | 1 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 3 | 2 | 6 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 3 | 2 | 6 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 3 | 2 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 2 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 5 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 3 | 2 | 6 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 8 | 0 | 0 | 8 |
| pyruvate kinase | 2 | 0 | 0 | 2 |
| perilipin-5 | 0 | 2 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
| perilipin-1 | 0 | 2 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Tubulin beta-4A chain | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 3 | 0 | 3 |
| Tubulin beta chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-3C chain | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 5 | 0 | 5 |
| Tumor necrosis factor receptor superfamily member 1A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 1 | 1 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Quinone oxidoreductase | 0 | 0 | 0 | 1 |
| Stromal cell-derived factor 1 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Tubulin alpha-1B chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-4A chain | 0 | 1 | 0 | 1 |
| Tubulin beta-4B chain | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 1 | 0 | 1 |
| Tubulin beta-2A chain | 0 | 1 | 0 | 1 |
| Tubulin beta-8 chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-3E chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-1A chain | 0 | 1 | 0 | 1 |
| Sortase A | 0 | 1 | 0 | 1 |
| Tubulin alpha-1C chain | 0 | 1 | 0 | 1 |
| Tubulin beta-6 chain | 0 | 1 | 0 | 1 |
| Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
| Tubulin beta-1 chain | 0 | 1 | 0 | 1 |
| Thrombopoietin | 5 | 0 | 0 | 5 |
| cytochrome P450 2C9 precursor | 6 | 0 | 0 | 6 |
| Angiotensin-converting enzyme | 0 | 8 | 0 | 8 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 4 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 8 | 0 | 8 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 1 precursor | 4 | 0 | 0 | 4 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| Glucocorticoid receptor | 0 | 15 | 3 | 23 |
| Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 12 | 0 | 12 |
| Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
| Glycine receptor subunit beta | 0 | 12 | 0 | 12 |
| Glycine receptor subunit alpha-2 | 0 | 12 | 0 | 12 |
| Glycine receptor subunit alpha-3 | 0 | 12 | 0 | 12 |
| TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
| Alkaline phosphatase, germ cell type | 0 | 1 | 0 | 1 |
| G protein-coupled receptor GPR35 | 0 | 0 | 1 | 1 |
| G-protein coupled receptor 35 | 0 | 0 | 1 | 1 |
| G-protein coupled receptor 35 | 0 | 0 | 1 | 1 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| D(1A) dopamine receptor | 10 | 0 | 0 | 10 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| chaperonin GroEL | 2 | 0 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
| Glycogen phosphorylase, brain form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| D | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 3 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 3 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Histone-lysine N-methyltransferase SETD7 | 0 | 2 | 0 | 2 |
| Transporter | 0 | 4 | 1 | 6 |
| nuclear receptor subfamily 1, group I, member 2 | 9 | 0 | 0 | 9 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 5 | 0 | 6 |
| Acetylcholine-binding protein | 0 | 2 | 1 | 3 |
| Soluble acetylcholine receptor | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 4 |
| Alpha-2B adrenergic receptor | 0 | 10 | 2 | 12 |
| Alpha-2C adrenergic receptor | 0 | 10 | 2 | 12 |
| Alpha-2A adrenergic receptor | 0 | 10 | 2 | 12 |
| Alpha-1D adrenergic receptor | 0 | 7 | 1 | 8 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 8 | 1 | 9 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 3 | 7 |
| Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
| Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
| Protein orai-2 | 0 | 1 | 0 | 1 |
| Protein orai-3 | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 3 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| Alpha-synuclein | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 8 | 0 | 0 | 8 |
| Estrogen receptor | 0 | 4 | 0 | 4 |
| Progesterone receptor | 0 | 4 | 1 | 6 |
| Mineralocorticoid receptor | 0 | 4 | 3 | 7 |
| Estrogen receptor beta | 0 | 4 | 0 | 4 |
| Menin | 0 | 0 | 1 | 1 |
| Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| Protein Rev | 0 | 0 | 1 | 1 |
| Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Chain A, Hypoxanthine Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE | 0 | 1 | 0 | 1 |
| Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain B, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain A, Xanthine phosphoribosyltransferase | 0 | 0 | 1 | 1 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Histidine triad nucleotide-binding protein 1 | 0 | 0 | 1 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 3 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 4 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 3 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 6 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 0 | 0 | 3 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 7 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 6 |
| Carbonic anhydrase | 0 | 0 | 0 | 3 |
| Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 6 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 6 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 3 |
| Snq2p | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 2 | 3 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 2 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Envelope glycoprotein | 0 | 0 | 1 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 2 | 3 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 4 | 1 | 6 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 2 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| alpha-galactosidase | 3 | 0 | 0 | 3 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | 0 | 1 | 0 | 1 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Microtubule-associated protein tau | 0 | 3 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 1 | 0 | 0 | 1 |
| Fatty acid synthase | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
| WD repeat-containing protein 5 | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase 2A | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Cytosolic endo-beta-N-acetylglucosaminidase | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 2 | 0 | 2 |
| Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
| Neurotensin receptor type 2 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase ABL1 | 0 | 2 | 0 | 2 |
| Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| galanin receptor type 3 | 0 | 1 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| Nischarin | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 2 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit epsilon | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Integrin beta | 0 | 0 | 1 | 1 |
| Glycoprotein IIb | 0 | 0 | 1 | 1 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| NFKB1 protein, partial | 5 | 0 | 0 | 5 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| CREB-binding protein | 1 | 0 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 2 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Endolysin | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 1 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Estrogen receptor 1 | 0 | 1 | 0 | 1 |
| fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Phenylethanolamine N-methyltransferase | 0 | 0 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| RGS12 | 1 | 0 | 0 | 1 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| Interleukin-5 | 0 | 1 | 0 | 1 |
| Interleukin-5 | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Interleukin-5 receptor subunit alpha | 0 | 1 | 0 | 1 |
| Pyridoxal kinase | 0 | 0 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Substance-K receptor | 0 | 1 | 1 | 2 |
| Neuromedin-K receptor | 0 | 1 | 1 | 2 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| BRCA1 | 1 | 0 | 0 | 1 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Caspase-4 | 0 | 1 | 0 | 1 |
| Caspase-5 | 0 | 1 | 0 | 1 |
| Caspase-9 | 0 | 1 | 0 | 1 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L5 | 0 | 1 | 0 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Plasminogen | 0 | 2 | 1 | 3 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |